ANTX Dividend History & Description — AN2 Therapeutics Inc
AN2 Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel medicines for patients with rare infectious diseases. Co.'s initial product candidate, epetraborole, an antibiotic under development as a once-daily, oral treatment for patients with chronic non-tuberculous mycobacterial lung disease. When considering the AN2 Therapeutics Inc stock dividend history, we have taken known splits into account, such that the ANTX dividend history is presented on a split-adjusted ("apples to apples") basis. AN2 Therapeutics Inc dividend history is presented both in graphical/chart form, and as a ANTX dividend history data table along the right-hand column.